Lesson Notes By Weeks and Term v4 - SHS 3
DIAGNOSTIC DEVICE
Download the Lessonotes Mobile Ghana app for faster lesson access on Android and iPhone.
DIAGNOSTIC DEVICE
Download the Lessonotes Mobile Ghana app for faster lesson access on Android and iPhone.
Subject: Biomedical Science
Class: SHS 3
Term: 2nd Term
Week: 17
Grade code: 3.3.1.LI.3
Strand code: 3
Sub-strand code: 1
Content standard code: 3.3.1.CS.1
Indicator code: 3.3.1.LI.3
Theme: BIOMEDICAL INTERVENTION
Subtheme: DIAGNOSTIC DEVICE
This page supports the lesson note with a companion video and a short classroom-ready summary.
For class groups and homework, share this lesson page so learners also get the summary, objectives, and full lesson context.
Welcome, future scientists and innovators! We know that creating a life-saving biomedical device is a brilliant achievement. However, an invention sitting in a laboratory helps no one. For a device to make a real impact in our communities—from a clinic in Accra to a CHPS compound in a village near Bolgatanga—it must be produced, distributed, and adopted by healthcare professionals and patients. This requires funding from investors. Today, we will learn the essential business skill of creating a compelling marketing plan to convince investors to believe in and fund your brilliant idea.
A marketing plan is a detailed roadmap that outlines how you will take your product from an idea to the hands of the end-user. For investors, it shows that you have a viable business idea, not just a good invention. Let's break down the essential components.
Component 1: The Executive Summary This is a short, powerful overview of your entire plan. You write it last, but it comes first in the document. It must grab the investor's attention immediately. What it includes: The problem your device solves, your solution (the device), who your customers are, and why your idea is a good financial investment. Example: "Ghana faces a rising tide of diabetes, with many cases going undiagnosed until complications arise. Our product, 'Gluco-Sela', is a revolutionary non-invasive glucose monitor that provides instant, painless blood sugar readings via a simple thumb scan. Targeting diabetic patients and at-risk individuals through pharmacies and clinics, we project capturing 5% of the market within three years, offering significant health benefits to Ghanaians and a strong return for investors."
Component 2: Problem and Solution (Value Proposition) This is where you clearly state the problem you are solving and why your device is the best solution. Problem: Describe the health issue in Ghana. Use statistics if possible. *e.g., "According to the Ghana Health Service, an estimated 7% of Ghanaian adults are living with diabetes, and many more are pre-diabetic and unaware of their condition. Current testing methods involve painful finger pricks, which discourages regular monitoring."* Solution (Your Device): Introduce your device. How does it work? What makes it unique or better than existing solutions? This is your Unique Value Proposition (UVP). UVP Formula: For [target customer] who [has a specific need], our [product name] is a [product category] that provides [key benefit]. Unlike [the competition/alternative], our product [key differentiator]. Example UVP: "For Ghanaian diabetics who need to monitor their blood sugar regularly but dislike painful finger pricks, Gluco-Sela is a handheld diagnostic device that provides instant glucose readings painlessly. Unlike traditional glucometers, our device uses near-infrared spectroscopy, eliminating the need for costly and uncomfortable test strips."
Component 3: Target Market Analysis Who will buy and use your product? Be specific. Investors need to know there's a real market. Primary Market: The main users (e.g., diagnosed diabetic patients). Secondary Market: Other potential users (e.g., hospitals, clinics, individuals at high risk of diabetes, health-conscious people). Market Size: Estimate how many potential customers exist in Ghana. *e.g., "With an adult population of over 18 million and a 7% diabetes prevalence, our primary market is approximately 1.26 million Ghanaians, with a potential secondary market of millions more."*